USPTO serial 77323539
LIDOFENAC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 9, 2010
- Examiner
- KEATING, MICHAEL P
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LIDOFENAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
Taichung, TW
Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
Taichung, TW
Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
Taichung, TW
Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MICHAEL D. SCHUMANN
MICHAEL D. SCHUMANN Hamre Schumann Mueller & Larson P C45 South Seventh Street, Suite 2700Minneapolis, MN 55402-0902UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medicines for human purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; drugs for medical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pharmaceutical preparations for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pills for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; pastilles for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; powder for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; capsules for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; ointments for pharmaceutical purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; analgesic preparations; oral analgesics; anti-inflammatories; oral anti-inflammatories; anesthetics for non-surgical use; anti-arthritic compositions and preparations; medicines for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; drugs and pharmaceutical preparations for human purposes for the relief of mild to moderate pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout, for the relief of the pain of Post-Herpetic Neuralgia, also referred to as post-shingles pain, and for the treatment of acute pain due to minor strains, sprains and contusions; antibiotic ointments, anti-inflammatory ointments, anti-itch ointments, pain relief ointments, antifungal creams for medical use; analgesic anti-inflammatory preparations; analgesics anti-inflammatory patches; nutritional supplements | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
- Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
- Other trademarks owned by YUNG SHIN PHARMACEUTICAL IND. CO., LTD.
- Other trademarks in Class 005
- Similar marks named LIDOFENAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 21, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 9, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 22, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 18, 2009 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Nov 18, 2009 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Nov 17, 2009 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Nov 16, 2009 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 2, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 2, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 9, 2009 | PDCB | PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED | — |
| Oct 9, 2009 | FAXX | FAX RECEIVED | — |
| Oct 7, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 7, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 3, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 3, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 9, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 9, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 9, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 2, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 19, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 19, 2008 | ALIE | ASSIGNED TO LIE | — |
| May 19, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 16, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2007 | NWAP | NEW APPLICATION ENTERED | — |